Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 501,493 $ 0
Prepaid expenses 1,324,605 6,380
Total current assets 1,826,098 6,380
Deferred offering costs associated with proposed public offering   56,483
Investment held in Trust Account 977,543,775  
Total Assets 979,369,873 62,863
Current liabilities:    
Accounts payable 27,964 23,450
Accrued expenses 323,245 33,033
Due to related party 497,675  
Total current liabilities 848,884 56,483
Deferred legal fees 18,182  
Deferred underwriting commissions 34,212,500  
Derivative warrant liabilities 38,914,670  
Total liabilities 73,994,236 56,483
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 90,037,563 and 0 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively 900,375,630  
Shareholders' Equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding  
Additional paid-in capital 10,845,128 22,556
Accumulated deficit (5,848,336) (18,620)
Total shareholders' equity 5,000,007 6,380
Total Liabilities and Shareholders' Equity 979,369,873 62,863
Class A Ordinary Shares    
Shareholders' Equity:    
Common Stock 771  
Total shareholders' equity 771 0
Class B Ordinary Shares    
Shareholders' Equity:    
Common Stock 2,444 2,444
Total shareholders' equity $ 2,444 $ 2,444